CRIGLER-NAJJAR SYNDROME TYPE II CAUSED BY HOMOZYGOUS DOUBLE MUTATION [T1456G, G211A] OF UGT1A1 GENE IN A TAIWANESE SIBLING

被引：1
|
作者：
Tseng, Y. -Y. [1 ]
Yang, Y. -J. [2 ]
Huang, S. -C. [3 ]
机构：
[1] Sin Lau Hosp, Dept Pediat, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Pediat, Tainan 70101, Taiwan
[3] Kuo Gen Hosp, Dept Pediat, Tainan, Taiwan
来源：
PEDIATRIC RESEARCH | 2010年 / 68卷
关键词：
D O I：
10.1203/00006450-201011001-00781
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
781
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [41] Crigler-Najjar syndrome type II in a Chinese boy resulting from three mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene and a family genetic analysis
    Bixia Zheng
    Guorui Hu
    Jin Yu
    Zhifeng Liu
    BMC Pediatrics, 14
  • [42] Crigler-Najjar syndrome type II in a Chinese boy resulting from three mutations in the bilirubin uridine 5′-diphosphate-glucuronosyltransferase (UGT1A1) gene and a family genetic analysis
    Zheng, Bixia
    Hu, Guorui
    Yu, Jin
    Liu, Zhifeng
    BMC PEDIATRICS, 2014, 14
  • [43] A novel missense mutation of the bilirubin UDP-glucuronosyltransferase gene in a Turkish patient with Crigler-Najjar syndrome type 1
    Maruo, Y
    Serdaroglu, E
    Iwai, M
    Takahashi, H
    Mori, A
    Bak, M
    Calkavur, T
    Sato, T
    Takeuchi, Y
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 (05): : 627 - 630
  • [44] Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene
    Francoual, J
    Rivierre, A
    Mokrani, C
    Khrouf, N
    Gottrand, F
    Myara, A
    Le Bihan, B
    Capel, L
    Lindenbaum, A
    Labrune, P
    HUMAN MUTATION, 2002, 19 (05) : 570 - 571
  • [45] Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1 (vol 7, pg 404, 2018)
    Apgar, J. F.
    Tang, J. P.
    Singh, P.
    Balasubramanian, N.
    Burke, J. M.
    Hodges, M. R.
    Lasaro, M. A.
    Lin, L.
    Millard, B. L.
    Moore, K.
    Jun, L. S.
    Sobolov, S.
    Wilkins, A. K.
    Gao, X.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (03): : 185 - 185
  • [46] A novel compound heterozygous variation of the uridine-diphosphoglucuronosyl transferase 1A1 gene that causes Crigler-Najjar syndrome type II
    Huang, CS
    Luo, GA
    Huang, MJ
    Chen, ES
    Young, TH
    Chao, YC
    PHARMACOGENETICS, 2001, 11 (07): : 639 - 642
  • [47] UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays
    Gailite, Linda
    Valenzuela-Palomo, Alberto
    Sanoguera-Miralles, Lara
    Rots, Dmitrijs
    Kreile, Madara
    Velasco, Eladio A.
    FRONTIERS IN GENETICS, 2020, 11
  • [48] A MUTATION IN BILIRUBIN URIDINE 5'-DIPHOSPHATE-GLUCURONOSYLTRANSFERASE ISOFORM-1 CAUSING CRIGLER-NAJJAR SYNDROME TYPE-II
    BOSMA, PJ
    GOLDHOORN, B
    ELFERINK, RPJO
    SINAASAPPEL, M
    OOSTRA, BA
    JANSEN, PLM
    GASTROENTEROLOGY, 1993, 105 (01) : 216 - 220
  • [49] Compound heterozygosity of a novel exon 3 frameshift (p.R357P fs☆24) mutation and Y486D mutation in exon 5 of the UGT1A1 gene in a Thai infant with Crigler-Najjar syndrome type 2
    Tesapirat, L.
    Nilyanimit, P.
    Wanlapakorn, N.
    Poovorawan, Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 3293 - 3299
  • [50] IDENTIFICATION OF A 2-BASE MUTATION IN THE BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE GENE AT THE UGT1 GENE-COMPLEX LOCUS IN 2 UNRELATED CRIGLER-NAJJAR TYPE-1 PATIENTS
    CIOTTI, M
    OBARAY, R
    MARTIN, M
    OWENS, IS
    FASEB JOURNAL, 1995, 9 (06): : A1267 - A1267
12345